Description
UCSF 20th Annual Osteoporosis New Insights in Research, Diagnosis, and Clinical Care 2023
Osteoporosis New Insights in Research
Overview
Osteoporosis New Insights in Research Now in its 20th year, and presented by the Department of Epidemiology and Biostatistics of the University of California, San Francisco School of Medicine, this 1-day virtual course features an expert faculty that will discuss the epidemiology, pathophysiology, diagnosis, and treatment of osteoporosis. The course will critically review current treatment options.
There will be an emphasis on recent developments and current controversies in the etiology, diagnosis, and management of osteoporosis. Additional special topics this year include the role for vitamin D in bone health, and racial differences and disparities in osteoporosis care.
TARGET AUDIENCE
The course will provide an update on current recommendations about screening and treatment of osteoporosis for physicians and other clinicians working with osteoporosis patients. It will also benefit researchers, technologists, and pharmaceutical or device company professionals who would find additional scientific background in the disease helpful. No prior clinical or scientific training in osteoporosis is required.
Objectives
- Screen for and diagnose osteoporosis according to the latest evidence-based standards of care;
- Interpret dual-energy X-ray absorptiometry (DXA) bone density scans and avoid common DXA pitfalls;
- Provide appropriate pharmacological treatment for osteoporosis, including antiresorptive and anabolic therapies;
- Assess the benefits and risks of continuing long-term antiresorptive osteoporosis therapy and determine optimal treatment duration;
- Understand the evidence for vitamin D in the optimization of bone health;
- Recognize racial differences and disparities in osteoporosis care
Course Chairs
Dennis M. Black, PhD
Professor of Epidemiology and Biostatistics
University of California, San Francisco
Anne L. Schafer, MD
Professor of Medicine and of Epidemiology and Biostatistics
University of California, San Francisco
Chief of Endocrinology and Metabolism, San Francisco VA Health Care System
Topics:
*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below
00_Syllabus_Intro.pdf
01_BMD FRAX_Harris.pdf
02_Bisphosphonates_Black.pdf
03_Denosumab_Eastell.pdf
04_Anabolic_Rosen.pdf
05_Anabolic_Schafer.pdf
06_Racial_Wright.pdf
07_VitD_Rosen.pdf
08_Monitoring_Wu.pdf
09_DXA_Sellmeyer.pdf
10_Sellmeyer.mp3
11_ClinRound Table.mp3
9_Wu.mp3
July 13.mp4 (6 hours 20 minutes)
MEP24001_Agenda.pdf
MEP24001_Syllabus.pdf
*Detail:
Thursday, July 13, 2023
SCREENING AND DIAGNOSIS
8:00 am Zoom Registration and login, housekeeping, overview
8:10 Osteoporosis Screening and Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis Steven T. Harris, MD, FACP, FASBMR
8:50 Q&A
ANTIRESORPTIVE TREATMENT
9:00 Bisphosphonate Efficacy, Duration, and Drug Holidays: Maximize Benefits and Minimize Risk Dennis M. Black, PhD
9:35 Q&A
9:45 Long-Term Treatment With and Following Denosumab Richard Eastell, MD, FRCP
10:15 Q&A
10:25 Break
ANABOLIC TREATMENT
10:45 Anabolic Agents: Mechanism, Efficacy, and Safety Clifford J. Rosen, MD
11:10 Incorporating Anabolic Treatments into Osteoporosis Regimens Anne L. Schafer, MD
11:40 Q&A
12:00 pm Lunch Break
SPECIAL TOPICS IN OSTEOPOROSIS
12:55 pm Racial Differences and Disparities in Osteoporosis Care Nicole C. Wright, PhD, MPH
1:20 Q&A
1:30 Vitamin D Clifford J. Rosen, MD
1:55 Q&A
2:05 Monitoring: Before, During and After Treatment Karin C. Wu, MD
2:30 Q&A
2:40 Break
2:55 DXA Interpretation and Pitfalls Deborah Sellmeyer, MD
3:35 Q&A
3:45 Clinical Roundtable: Q&A with a Panel of Physicians Deborah E. Sellmeyer, MD Clifford J. Rosen, MD Steven T. Harris, MD, FACP, FASBMR Dolores M. Shoback, MD Anne L. Schafer, MD
4:30 Adjourn
